Dr. Brandt F. Eichman’s lab at Vanderbilt University focuses on understanding how our cells replicate DNA and repair any damage that might occur during this process. Their research is crucial because mistakes in DNA replication can lead to cancer and other diseases. The team investigates the complex interactions between various proteins involved in DNA replication, aiming to uncover how these proteins work together to maintain genomic stability and prevent disease.

Dr. Melissa Ellermann's lab at the University of South Carolina studies how the endocannabinoid system affects gut bacteria, particularly during infections caused by Escherichia coli. The research aims to understand how this signaling system can lower the gut's defenses against harmful bacteria, potentially worsening chronic digestive diseases like Crohn's disease. By using mouse models and advanced genetic techniques, the lab investigates the complex interactions between host signals and microbial behavior.

Dr. Brooke Howitt's lab at Stanford University focuses on understanding the complex nature of endometrial cancer, which is the most common cancer affecting the female reproductive system. By using advanced techniques to analyze single cells, the lab aims to uncover how tumors differ at a genetic level and how these differences affect treatment responses. This research will help identify better ways to classify, treat, and predict outcomes for patients with this disease.

Dr. Andrew Patterson's lab investigates how environmental chemicals influence the gut microbiota and affect overall health. By studying the interactions between toxic exposures and gut microbes, the lab aims to uncover mechanisms that link environmental factors to diseases like metabolic disorders and inflammatory bowel diseases. The research has broader implications for public health, particularly in developing new probiotic treatments and improving risk assessments for chemical exposures.

Dr. Pamela J. Lein's lab at UC Davis focuses on understanding how environmental toxins, specifically polychlorinated biphenyls (PCBs) and traffic-related air pollution, affect brain development and contribute to diseases like Alzheimer's. By using advanced animal models, the lab investigates the mechanisms by which these pollutants disrupt normal neurological processes, aiming to inform public health strategies for minimizing risks associated with environmental exposures.

Dr. Shuo Wei's lab at the University of Delaware focuses on understanding how specific proteins called ephrins and their receptors interact and influence cell signaling and adhesion. This research is important because disruptions in these interactions can lead to serious health issues, including developmental and neurological disorders. The lab aims to investigate how these proteins are processed by enzymes and to explore their role in cell communication, which could help identify new therapeutic strategies for related diseases.

Dr. Elizabeth E. Brown's lab at the University of Alabama at Birmingham focuses on understanding how epigenetic changes in DNA influence the risk of developing certain blood disorders, particularly Monoclonal Gammopathy of Undetermined Significance (MGUS) and Multiple Myeloma (MM). By studying the DNA methylome, the lab aims to uncover biological markers linked to these conditions, which disproportionately affect African Americans. This research has the potential to improve clinical strategies for monitoring and managing these diseases.

Dr. Shelley L. Berger's lab at the University of Pennsylvania focuses on understanding the link between epigenetics and metabolism in cancer. The lab studies how changes in these pathways can affect gene expression and contribute to cancer development. They aim to develop new therapeutic strategies by investigating the role of specific enzymes and regulatory elements in these processes.

Dr. Sriram Venneti's lab focuses on understanding childhood ependymomas, a type of brain tumor that often leads to poor outcomes due to limited treatment options. The research investigates how epigenetic factors and changes in cellular metabolism drive these tumors, aiming to develop effective therapies that target both aspects simultaneously. By exploring the mechanisms behind tumor growth and behavior, the lab seeks to improve prognoses for affected children.

Dr. Tomasz Cierpicki's lab at the University of Michigan focuses on understanding the role of epigenetic changes in cancer, specifically breast cancer and leukemia. The laboratory investigates small molecule inhibitors that target specific proteins involved in gene regulation, aiming to develop new treatments that can inhibit cancer cell growth and promote differentiation of stem cells. Researchers will gain insights into molecular biology and drug development processes relevant for cancer therapy.

Dr. Andrei Seluanov's lab at the University of Rochester focuses on understanding how the stability of the epigenome is regulated during aging, particularly through the action of the SIRT6 protein. The lab investigates the molecular mechanisms that underlie age-related declines in cell and organ function, leveraging techniques like mass spectrometry and genetic models to explore how SIRT6 influences DNA repair and longevity. Their work aims to discover new treatments for age-related diseases by revealing insights into the aging process.

Dr. David McClay's lab at Duke University studies how cells transform during development, particularly focusing on a process called epithelial to mesenchymal transition (EMT). This process is key in forming the tissues of embryos and, when dysregulated, can contribute to cancer metastasis and birth defects. Using sea urchins as a model, the lab investigates the molecular mechanisms behind EMT to identify which factors drive these changes in cell behavior and how they can be manipulated to improve health outcomes.

Dr. Jonathan A. Epstein's lab at the University of Pennsylvania focuses on designing advanced immune therapies to improve cardiac health. Specifically, the research targets the engineering of T regulatory cells to combat inflammation and fibrosis in the heart after events such as myocardial infarction, which can lead to heart failure. Through innovative techniques like lipid nanoparticle delivery, the lab aims to enhance the healing process and overall heart function.

Dr. Merav Socolovsky's lab focuses on understanding the process of red blood cell formation, called erythropoiesis. The lab investigates how specific signaling pathways, specifically those involving EpoR and Stat5, regulate protein synthesis and ribosome production during the critical stages of erythroid cell development. This research aims to uncover the connections between cell cycle duration, cell growth, and the quality of DNA replication, which could have important implications for both developmental biology and diseases like anemia and cancer.

Dr. Peng Ji's lab at Northwestern University focuses on understanding the development of red blood cells and the impact of inflammation on blood disorders. They compare the unique environments that support red blood cell development in mice and humans, aiming to uncover critical differences that could lead to new treatments for diseases like myelodysplastic syndromes (MDS). The research uses advanced techniques to study how immune responses affect blood cell production and maturation, which is vital for addressing health issues associated with aging and chronic inflammation.

Dr. Daria Esterhazy's lab focuses on understanding how certain immune cells, known as innate lymphocytes, develop and function in the body. These cells play a crucial role in our immune responses, particularly in how we react to infections and other challenges. The research involves exploring the genetic regulation of these cells to better understand their roles in health and disease, which could lead to new treatments for autoimmune diseases and infections.

Dr. Weiping Zhang's lab focuses on developing a novel vaccine called MecVax to combat diarrheal diseases caused by enterotoxigenic Escherichia coli (ETEC), which significantly affects children in developing countries. The lab's long-term goal is to create effective vaccines against major bacterial pathogens to reduce childhood mortality and improve health outcomes. This promising vaccine aims to offer broad protection by targeting multiple ETEC components, making it a significant advancement in public health.

David T Evans' lab at the University of Wisconsin-Madison focuses on understanding how natural killer (NK) cells recognize and respond to viral infections, particularly simian immunodeficiency virus (SIV), a model for HIV. The research explores the interactions between NK cell receptors and their ligands, aiming to uncover the mechanisms that enable NK cells to distinguish between infected and healthy cells. The findings may contribute significantly to the development of NK cell-based therapies for viral infections.

Dr. Scott A. Oakes' lab at the University of Chicago focuses on understanding how the exocrine pancreas, specifically the enzyme pancreatic elastase, impacts the health of insulin-producing beta cells and contributes to type 1 diabetes. The lab investigates the crosstalk between exocrine and endocrine cells in the pancreas, exploring how dysregulation can trigger inflammation and autoimmunity. Their research aims to develop new therapeutic strategies to protect beta cells and potentially prevent type 1 diabetes.

Dr. Wei Guo's lab at the University of Pennsylvania focuses on understanding exosomes, which are tiny vesicles secreted by cells that play a crucial role in communication between cells. These exosomes carry molecules that can influence how other cells behave, impacting important processes such as cancer progression and immune responses. The lab investigates the mechanisms behind exosome secretion and how this process may be manipulated for therapeutic purposes, including potential cancer treatments.